The performance of companies tied to Viagra's legacy presents a intricate investment picture . While the initial success generated substantial profits , generic copies have significantly impacted market share . Investing in associated pharmaceutical businesses now requires a thorough assessment of proprietary protection , evolving healthcare shifts